Events

Webinar: the applicant approach towards Missions
DEC
Fri
06
10:00 - 11:40

This was 6 months ago

Location

online

Programmes
Health Climate, Energy, Mobility Missions

The network of NCPs for the Horizon Europe missions (NCP4missions) will organise a series of workshops designed for applicants and stakeholders working within the five EU Missions themes. The first webinar will take place on the 6th of December. It will provide a overview of the five missions and the process applicants need to go through including some testimonials. Please find below the preliminary programme:

  • 15’ NCP4Missions: intro to the project and tools for applicants, Noemi Tesauro (APRE)
  • 20’ The Eu Missions’ outlook: an overview of the five EU Missions, Maike Heidelberger(FZJ)
  • 10’ Coffee Break
  • 45’ Roundtable: Insights from the applicants on their Missions' journey
    • Mission Cities Alessia Pelucchetti (RINA Consulting SPA) (TBC)
    • Mission Climate Eric Mino (OiEau) 
    • Mission Ocean Angela Schultz-Zehden (Submariner Network for Blue Growth Ewiv (TBC)
    • Mission Soil Kyriakos Panopoulos (CERTH) (TBC)
    • Mission Cancer  Klaus Pantel (UKE)
  • 10’ Conclusions APRE

You can register for this event via this form

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.